376 related articles for article (PubMed ID: 32971385)
1. Electroencephalographic findings in antileucine-rich glioma-inactivated 1 (LGI1) autoimmune encephalitis: A systematic review.
Roberto KT; Espiritu AI; Fernandez MLL; Gutierrez JC
Epilepsy Behav; 2020 Nov; 112():107462. PubMed ID: 32971385
[TBL] [Abstract][Full Text] [Related]
2. [Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].
Ishibashi H; Neshige S; Aoki S; Ueno H; Iida K; Maruyama H
Rinsho Shinkeigaku; 2020 Nov; 60(11):778-785. PubMed ID: 33115994
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.
Huang X; Fan C; Gao L; Li L; Ye J; Shen H
J Neuropsychiatry Clin Neurosci; 2022; 34(2):141-148. PubMed ID: 34794327
[TBL] [Abstract][Full Text] [Related]
4. A case of pediatric anti-leucine-rich glioma inactivated 1 encephalitis with faciobrachial dystonic seizure.
Jang S; Kim SY; Kim WJ; Chae JH; Kim KJ; Lim BC
Brain Dev; 2023 Jun; 45(6):348-353. PubMed ID: 36858863
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Electroencephalographic Features of the Seizures in Neuronal Surface Antibody-Associated Autoimmune Encephalitis.
Wang Y; Yu Y; Hu Y; Li Y; Song F; Wang Y
Front Neurol; 2020; 11():280. PubMed ID: 32431657
[No Abstract] [Full Text] [Related]
6. Faciobrachial motor seizures: A more apt description?
Muthusamy S; Foroush NC; Seneviratne U
Epilepsy Behav Rep; 2021; 16():100476. PubMed ID: 34505053
[TBL] [Abstract][Full Text] [Related]
7. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.
Irani SR; Stagg CJ; Schott JM; Rosenthal CR; Schneider SA; Pettingill P; Pettingill R; Waters P; Thomas A; Voets NL; Cardoso MJ; Cash DM; Manning EN; Lang B; Smith SJ; Vincent A; Johnson MR
Brain; 2013 Oct; 136(Pt 10):3151-62. PubMed ID: 24014519
[TBL] [Abstract][Full Text] [Related]
8. Clinical and electrographic characteristics of seizures in LGI1-antibody encephalitis.
Li LH; Ma CC; Zhang HF; Lian YJ
Epilepsy Behav; 2018 Nov; 88():277-282. PubMed ID: 30332659
[TBL] [Abstract][Full Text] [Related]
9. Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.
Chen C; Wang X; Zhang C; Cui T; Shi WX; Guan HZ; Ren HT; Shao XQ
Epilepsy Behav; 2017 Dec; 77():90-95. PubMed ID: 29050866
[TBL] [Abstract][Full Text] [Related]
10. Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.
Li Z; Cui T; Shi W; Wang Q
Medicine (Baltimore); 2016 Jul; 95(28):e4244. PubMed ID: 27428233
[TBL] [Abstract][Full Text] [Related]
11. Case report: Anti-IgLON5 disease and anti-LGI1 encephalitis following COVID-19.
Li Y; Jia Y
Front Immunol; 2023; 14():1195341. PubMed ID: 37383232
[TBL] [Abstract][Full Text] [Related]
12. Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia.
Yuan X; Man X; Zhang J; Sun J; Liang J; Ma H; Tao S; Guo D; Liu L
Intern Med; 2020; 59(2):271-275. PubMed ID: 31941873
[TBL] [Abstract][Full Text] [Related]
13. Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis.
Li TR; Zhang YD; Wang Q; Shao XQ; Lv RJ
CNS Neurosci Ther; 2021 Oct; 27(10):1173-1181. PubMed ID: 34291554
[TBL] [Abstract][Full Text] [Related]
14. LGI1-negative faciobrachial dystonic-like seizures originating from the insula.
Patira R; Khatri V; Gutierrez C; Zubkov S
Epilepsy Behav Case Rep; 2016; 6():33-5. PubMed ID: 27489774
[TBL] [Abstract][Full Text] [Related]
15. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study.
Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J;
Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.
Zhao Q; Sun L; Zhao D; Chen Y; Li M; Lu Y; Li G; Lin W
Clin Neurol Neurosurg; 2021 Apr; 203():106542. PubMed ID: 33706063
[TBL] [Abstract][Full Text] [Related]
17. A rare case of antileucine-rich glioma-inactivated 1 encephalitis in a 14-year-old girl.
Özçifçi G; Kamaşak T; Keskin DB
Turk J Pediatr; 2022; 64(3):566-570. PubMed ID: 35899570
[TBL] [Abstract][Full Text] [Related]
18. Pilomotor Seizures in a Patient With LGI1 Encephalitis.
Yang J; Sun Q; Yang G
Front Neurol; 2020; 11():61. PubMed ID: 32153488
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.
Chen L; Su T; Liu Y
BMC Neurol; 2023 Jun; 23(1):253. PubMed ID: 37391712
[TBL] [Abstract][Full Text] [Related]
20. Long-term seizure outcomes in patients with anti-Leucine-rich glioma-inactivated 1 encephalitis.
Lin N; Liu Q; Chen J; Jin L; Huang Y; Lu Q; Guan H
Epilepsy Behav; 2021 Sep; 122():108159. PubMed ID: 34229158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
